Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.3429 | 70 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.08065 | 67 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.33544 | 70 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.97826 | 66 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 4.09738 | 68 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.46506 | 71 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.51987 | 72 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.20131 | 68 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 4.13084 | 68 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 4.05797 | 67 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 4.3902 | 70 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 4.04633 | 67 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.32623 | 70 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 4.23792 | 69 |